Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/- in-vitro and express KIR2DL2/DL3 and KIR3DL1

peer-reviewed
Erstveröffentlichung
2021-05-04Authors
Euchner, Johanna
Sprissler, Jasmin
Cathomen, Toni
Fürst, Daniel
Schrezenmeier, Hubert
Wissenschaftlicher Artikel
Published in
Frontiers in Immunology ; 12 (2021). - Art.-Nr. 640672.. - eISSN 1664-3224
Link to original publication
https://dx.doi.org/10.3389/fimmu.2021.640672Institutions
UKU. Institut für TransfusionsmedizinInternational Graduate School in Molecular Medicine Ulm (IGradU)
UKU. Klinik für Kinder- und Jugendmedizin
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
External cooperations
Albert-Ludwigs-Universität FreiburgDocument version
published version (publisher's PDF)Abstract
The differentiation of human induced pluripotent stem cells (hiPSCs) into T and natural killer (NK) lymphocytes opens novel possibilities for developmental studies of immune cells and in-vitro generation of cell therapy products. In particular, iPSC-derived NK cells gained interest in adoptive anti-cancer immunotherapies, since they enable generation of homogenous populations of NK cells with and without genetic engineering that can be grown at clinical scale. However, the phenotype of in-vitro generated NK cells is not well characterized. NK cells derive in the bone marrow and mature in secondary lymphoid tissues through distinct stages from CD56brightCD16- to CD56dimCD16+ NK cells that represents the most abandoned population in peripheral blood. In this study, we efficiently generated CD56+CD16+CD3- NK lymphocytes from hiPSC and characterized NK-cell development by surface expression of NK-lineage markers. Hematopoietic priming of hiPSC resulted in 31.9% to 57.4% CD34+CD45+ hematopoietic progenitor cells (HPC) that did not require enrichment for NK lymphocyte propagation. HPC were further differentiated into NK cells on OP9-DL1 feeder cells resulting in high purity of CD56brightCD16- and CD56brightCD16+ NK cells. The output of generated NK cells increased up to 40% when OP9-DL1 feeder cells were inactivated with mitomycine C. CD7 expression could be detected from the first week of differentiation indicating priming towards the lymphoid lineage. CD56brightCD16-/+ NK cells expressed high levels of DNAM-1, CD69, natural killer cell receptors NKG2A and NKG2D, and natural cytotoxicity receptors NKp46, NKp44, NKp30. Expression of NKp80 on 40% of NK cells, and a perforin+ and granzyme B+ phenotype confirmed differentiation up to stage 4b. Killer cell immunoglobulin-like receptor KIR2DL2/DL3 and KIR3DL1 were found on up to 3 and 10% of mature NK cells, respectively. NK cells were functional in terms of cytotoxicity, degranulation and antibody-dependent cell-mediated cytotoxicity.
Publication funding
Open-Access-Förderung durch die Medizinische Fakultät der Universität Ulm
Is supplemented by
https://www.frontiersin.org/articles/10.3389/fimmu.2021.640672/full#supplementary-materialSubject headings
[GND]: Induzierte pluripotente Stammzelle | Blutstammzelle | Natürliche Killerzelle[MeSH]: Induced pluripotent stem cells | Hematopoietic stem cells | Killer cells, Natural
[Free subject headings]: natural killer (NK) cells | hematopoietic progenitor cells (HPC) | NK cell differentiation | OP9-DL1
[DDC subject group]: DDC 570 / Life sciences | DDC 610 / Medicine & health
Metadata
Show full item recordDOI & citation
Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-38915
Euchner, Johanna et al. (2021): Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/- in-vitro and express KIR2DL2/DL3 and KIR3DL1. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-38915
Citation formatter >